KATIE BASCH: Open Payments
NPI 1326583493 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 12 payments from 7 companies in 2025. Trend: 2023 $123 · 2024 $240 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $83 |
| Ossur Americas, Inc. | 1 | $57 |
| Pacira Pharmaceuticals Incorporated | 2 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| ERMI LLC | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
Products named: DALVANCE, Exparel, JOURNAVX, XCELL, PROCLAIM.
Industry payments across AL — which companies pay providers there.
